Contact
searchSearch
HMP Global
Teaching Collection

The Regurgitant Aortic Valve

Morton J. Kern, MD, MSCAI, FACC, FAHA
01/10/2022

Related Content

Cath Lab Digest
Meeting Update
TCT 2026: Late-Breaking Trials and Clinical Science to Watch
10/15/2026
Rebecca Kapur, Managing Editor, CLD
Preview the TCT 2026 late-breaking trials most likely to matter in the cath lab, from CT- and physiology-guided PCI to drug-coated balloons, transcatheter valve intervention, cerebral protection during TAVR, and renal denervation.
Preview the TCT 2026 late-breaking trials most likely to matter in the cath lab, from CT- and physiology-guided PCI to drug-coated balloons, transcatheter valve intervention, cerebral protection during TAVR, and renal denervation.
Preview the TCT 2026...
10/15/2026
Cath Lab Digest
At Newark Beth Israel Medical Center’s Hybrid Cath Lab Celebration.
New Hybrid Lab
Newark Beth Israel Medical Center Opens Hybrid Cardiac Cath Lab
09/15/2026
The new hybrid cardiac catheterization lab is a 730-square-foot suite equipped with advanced imaging equipment to perform complex minimally invasive procedures with greater precision, such as Transcatheter Aortic Valve Repair (TAVR),...
The new hybrid cardiac catheterization lab is a 730-square-foot suite equipped with advanced imaging equipment to perform complex minimally invasive procedures with greater precision, such as Transcatheter Aortic Valve Repair (TAVR),...
The new hybrid cardiac...
09/15/2026
Cath Lab Digest
Ultrasound
Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging
08/12/2026
VueJect® strengthens Bracco's integrated contrast-enhanced ultrasound (CEUS) ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging.
VueJect® strengthens Bracco's integrated contrast-enhanced ultrasound (CEUS) ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging.
VueJect® strengthens Bracco's...
08/12/2026
Cath Lab Digest
Valve Disease
Serotonin Pathway Linked to Faster Progression of Degenerative Mitral Regurgitation
07/15/2026
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve. The...
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve. The...
Serotonin is usually associated...
07/15/2026
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Shockwave C2 Aero Fly Catheter
Coronary Intravascular Lithotripsy
Johnson & Johnson Launches Next-Generation Shockwave C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half
10/20/2026
SANTA CLARA, Calif.-- Johnson & Johnson announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL Catheter designed to treat a broad range of calcified coronary artery lesions in half the time as previous coronary IVL devices.1...
SANTA CLARA, Calif.-- Johnson & Johnson announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL Catheter designed to treat a broad range of calcified coronary artery lesions in half the time as previous coronary IVL devices.1...
SANTA CLARA, Calif.-- Johnson...
10/20/2026
Cath Lab Digest
FDA Approvals
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
10/20/2026
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the treatment of deep vein thrombosis (DVT) to the company's Lightning™ computer assisted vacuum thrombectomy (CAVT™)...
ALAMEDA, Calif. -- Penumbra,...
10/20/2026
Cath Lab Digest
Vertex PE System (Jupiter Endovascular)
Pulmonary Embolism
Jupiter Endovascular Announces Publication of SPIRARE II Pivotal Trial Results Showing Vertex Thrombectomy System Normalized Hemodynamics in 50% of Pulmonary Embolism Patients
10/19/2026
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the company’s proprietary Transforming Fixation (TFX) platform technology, a single catheter designed to navigate flexibly through the right heart and stabilize on-demand in the pulmonary arteries for precise,...
The Vertex system leverages the...
10/19/2026
Cath Lab Digest
aortic strategy
New Aortic Root Enlargement Technique May Preserve Future TAVI Options After SAVR
10/15/2026
In the spirit of modern ‘lifetime management’, consideration should therefore be given as early as the first procedure to which options remain open for subsequent interventions – such as transcatheter aortic valve implantation (TAVI) within...
In the spirit of modern ‘lifetime management’, consideration should therefore be given as early as the first procedure to which options remain open for subsequent interventions – such as transcatheter aortic valve implantation (TAVI) within...
In the spirit of modern...
10/15/2026
Cath Lab Digest
Cardiology Compensation & Outlook
MedAxiom Releases 2026 Cardiovascular Provider Compensation & Production Survey Report, Revealing Record Compensation, Rising Productivity and Growing Workforce Demands
10/15/2026
National benchmarking report includes data from 205 cardiovascular programs and 6,476 physicians and advanced practice providers.
National benchmarking report includes data from 205 cardiovascular programs and 6,476 physicians and advanced practice providers.
National benchmarking report...
10/15/2026
Cath Lab Digest
ACC Scientific Statement
Exercise Should Be Prescribed as a Core Component of Cardiovascular Care
10/15/2026
WASHINGTON — Exercise should be prescribed as a foundational component of cardiovascular disease (CVD) prevention and treatment, according to a new American College of Cardiology Scientific Statement published today...
WASHINGTON — Exercise should be prescribed as a foundational component of cardiovascular disease (CVD) prevention and treatment, according to a new American College of Cardiology Scientific Statement published today...
WASHINGTON — Exercise...
10/15/2026
Cath Lab Digest
Renal Denervation
TIME Names Recor Medical’s Paradise Ultrasound Renal Denervation System One of the Best Inventions of 2026
10/15/2026
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal...
10/15/2026
Cath Lab Digest
Surgical Gloves
Mölnlycke Launches MyFit by Biogel to Bring More Inclusive Sizing to Surgical Gloves
10/14/2026
MyFit™ by Biogel® is designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
MyFit™ by Biogel® is designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
MyFit™ by Biogel® is designed to...
10/14/2026
Cath Lab Digest
Heart Failure
PRAISE-HM3 Real-World Data Show Decline in Aspirin Use After HeartMate 3 Implantation
10/14/2026
New findings presented at HFSA 2026 examine changes in antithrombotic management following ARIES-HM3 and the HeartMate 3 FDA labeling update.
New findings presented at HFSA 2026 examine changes in antithrombotic management following ARIES-HM3 and the HeartMate 3 FDA labeling update.
New findings presented at HFSA...
10/14/2026
Cath Lab Digest
Bioresorbable Scaffolds
REVA Medical Announces Motiv Sirolimus-Eluting Bioresorbable Vascular Scaffold Live Case and Late-Breaking BTK Trial Results at VIVA26
10/08/2026
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
SAN DIEGO -- REVA Medical,...
10/08/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use